Bibliography
- Webber MJ , TongersJ, NewcombCJet al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc. Natl Acad. Sci. 108, 13438–43 (2011).
- News. Therapeutic Delivery2(10), 1221–1223 (2011).
- Rider TH , ZookCE, BoettcherTLet al. Broad-spectrum antiviral therapeutics. PLoS One 6, e22572 (2011).
Patents
- Oliver K, Kaufmann J: US0274116A1 (2008).
- Plachetka JR: US6060499 (2000).
- Plachetka JR: US6586458 (2003).
- Plachetka JR, Kothapalli VM, Gilbert DL: US7332183 (2008).
- Kellogg S, Chuang H, Barman S et al.: US7963917 (2011).
- Cook RO, Shrewsbury SB, Ramadan NN et al.: US7994197 (2011).
Websites
- Merck plan to cut 12K more jobs aims to save $1.5B. www.fiercepharma.com/story/merck-plan-cut-12k-more-jobs-aims-save-15b/2011-07-29
- Merck shuts down RNAi research center in SF, cutting 50 jobs. www.xconomy.com/san-francisco/2011/07/29/merck-shuts-down-rnai-research-center-in-sf-cutting-50-jobs
- Roche dumps RNAi, sends shock waves through Alnylam, Tekmira. www.xconomy.com/national/2010/11/17/roche-dumps-rnai-sends-shock-waves-through-alnylam-tekmira
- Novartis wake-up call for Alnylam. http://rnaitherapeutics.blogspot.com/2010/09/novartis-wake-up-call-for-alnylam.html
- Bristol-Myers Squibb to acquire Amira Pharmaceuticals. www.businesswire.com/news/bms/20110721007018/en
- Bristol-Myers Squibb to acquire Amira Pharmaceuticals. www.amirapharm.com/articles/BMS-AMIRA_Press%20Relese_July%2021%202011.html
- Merck and Roche expand agreement in fight against chronic hepatitis C. www.fiercepharma.com/press_releases/merck-and-roche-expand-agreement-fight-against-chronic-hepatitis-c?utm_medium=nl&utm_source=internal
- Start-up Vaxxas lands $16.4M for vaccine nanopatch. www.fiercevaccines.com/story/start-vaxxas-lands-1646m-vaccine-nanopatch/2011-08-03
- Big deal for nano biotech company. www.fiercebiotech.com/press-releases/big-deal-nano-biotech-company
- Acceleron Pharma announces a global collaboration with Celgene Corporation on ACE-536 program. www.acceleronpharma.com/content/news/press-releases/detail.jsp/q/news-id/202
- Array announces new oncology agreement with Genentech. http://phx.corporate-ir.net/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=1594347
- US FDA approves new medicine BRILINTA (ticagrelor) for use in the USA. www.astrazeneca.com/Media/Press-releases/Article/20110720-fda-approves-brilinta-us
- US Food and Drug Administration approves subcutaneous formulation of ORENCIA® (abatacept), a proven non-anti-TNF biologic for adults with moderate to severe rheumatoid arthritis. www.bms.com/news/press_releases/pages/default.aspx? RSSLink= http://www.businesswire.com/news/bms/20110729006247/en&t=634475600483187694
- Roche‘s RoACTEMRA approved in Europe for children living with a rare and severe form of arthritis. www.roche.com/media/media_releases/med-cor-2011–08–03.htm
- First novel blood thinner in 50 years for the prevention of strokes caused by common heart rhythm disorder, approved in Europe. www.boehringer-ingelheim.com/news/news_releases/press_releases/2011/04_aug_2011_dabigatran.html
- Edurant® 96-week Phase III safety and efficacy data presented at international AIDS Society conference www.jnj.com/connect/news/all/edurant-96-week-phase-3-safety-and-efficacy-data-presented-at-international-aids-society-conference
- Impax and GSK announce positive topline results of ASCEND-PD Phase III study of IPX066 in advance Parkinson‘s disease. www.gsk.com/media/pressreleases/2011/2011-pressrelease-580727.htm
- GSK announces positive topline results of Phase III study of IPX066 in advanced Parkinson‘s disease. www.gsk.com/media/pressreleases/2011/2011_pressrelease_10040.htm
- Data on IPX066 ADVANCE-PD and APEX-PD Phase III studies to be presented at the International Congress of Parkinson‘s Disease and Movement Disorders Conference. http://phx.corporate-ir.net/phoenix.zhtml?c=67240&p=irol-newsArticle_ipharma&ID=1569621&highlight=
- Silence Therapeutics receives Notice of Allowance for new US Patent covering novel small interfering RNA (siRNA) delivery technology. www.silence-therapeutics.com/content/newsandevents/stories/2011/release_030811.pdf
- POZEN patents upheld in Treximet patent litigation. http://phx.corporate-ir.net/phoenix.zhtml?c=121701&p=irol-newsArticle_Print&ID=1593982&highlight=
- Echo Therapeutics announces multiple patents and trademark grants. www.echotx.com/press-releases.shtml?id=47
- MAP Pharmaceuticals issued US Patent for methods of achieving rapid relief of migraine and minimizing side effects based upon pharmacokinetic profile. http://ir.mappharma.com/releasedetail.cfm?ReleaseID=598735
- Pfizer wins Viagra patent trial. www.pfizer.com/news/press_releases/pfizer_press_releases.jsp#guid=20110815005757en&source=RSS_2011&page=1
- Pfizer wins case to keep Viagra patent. www.ft.com/cms/s/0/fa10b290-c753–11e0–9cac-00144feabdc0.html#axzz1VBrw6XKY
- New drug could cure nearly any viral infection. http://web.mit.edu/newsoffice/2011/antiviral-0810.html